Pro-inflammatory cytokine genetic variants show variable susceptibility to mild cognitive impairment, alzheimer's disease and frontotemporal dementia in South India
- PMID: 40728724
- DOI: 10.1007/s10048-025-00834-7
Pro-inflammatory cytokine genetic variants show variable susceptibility to mild cognitive impairment, alzheimer's disease and frontotemporal dementia in South India
Abstract
Dementia is a general term for loss of memory, ling and other thinking abilities that are severe enough to interfere with daily life. It is very crucial to distinguish the different forms of dementia such as Alzheimer's disease (AD), frontotemporal dementia (FTD) and amnestic mild cognitive impairment (MCI) at phenotypic and genetic level. In India, the estimated prevalence of dementia for adults more than 60 years old is reported to be 7.4%. It is known that immune response gets compromised with age and this brings the immune hypothesis into the core of neurodegeneration, that need critical investigation. To address this concern a battery of pro and anti-inflammatory cytokine gene variants was screened in patients diagnosed with AD (n = 150), FTD (n = 65) and MCI (n = 70) and compared with age-matched cognitively normal controls (n = 250) from a clinical cohort of South India (Kerala). The genotyping results show that rs1800796 GG and GC genotypes in IL-6 may confer a genetic susceptibility for AD group, whereas IL-1β, rs1143634, IL-6 promoter variants, rs1800795 (G allele) and rs1800796 (GC genotype) and three TNF variants, rs361525 (AA genotype), rs1800629 (GG genotype) and rs1799964 (CC genotype and C allele) could play an important role in the susceptibility to MCI group. In FTD, TNF promoter variant rs1800629 AA genotype showed a significant association compared to controls. These findings suggest that proinflammatory cytokine gene variations may confer variable risk for AD, MCI and FTD in the analyzed population, highlighting the need for further research to elucidate the underlying mechanisms. The environmental and inflammatory threshold are defined by genetic risk variants of inflammation. Identifying genetic risk factors for inflammation might help in defining how age and chronicity of inflammation can define and distinguish dementia and its subtypes.
Keywords: Alzheimer’s disease; Cytokines; Dementia; Frontotemporal dementia; Mild cognitive impairment; Neuroinflammation.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Disclosure: None of the authors have potential conflicts of interest.
Similar articles
-
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Jul 27;7:CD010783. doi: 10.1002/14651858.CD010783.pub3. PMID: 25740785 Free PMC article. Updated.
-
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2. Cochrane Database Syst Rev. 2015. PMID: 26102272 Free PMC article.
-
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884. Cochrane Database Syst Rev. 2017. PMID: 29164602 Free PMC article.
-
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Cochrane Database Syst Rev. 2014. PMID: 24913723 Free PMC article.
-
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2. Cochrane Database Syst Rev. 2017. PMID: 29164603 Free PMC article.
References
-
- Li X, Feng X, Sun X et al (2022) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2019. Front Aging Neurosci 14:937486. https://doi.org/10.3389/fnagi.2022.937486 - DOI
-
- Kalaria R, Maestre G, Mahinrad S et al (2024) The 2022 symposium on dementia and brain aging in low- and middle-income countries: highlights on research, diagnosis, care, and impact. Alzheimers Dement 20:4290–4314. https://doi.org/10.1002/alz.13836 - DOI
-
- Lee J, Meijer E, Langa KM et al (2023) Prevalence of dementia in india: National and state estimates from a nationwide study. Alzheimer’s Dement 19:2898–2912. https://doi.org/10.1002/alz.12928 - DOI
-
- Ravindranath V, Sundarakumar JS (2021) Changing demography and the challenge of dementia in India. Nat Rev Neurol 17:747–758. https://doi.org/10.1038/s41582-021-00565-x - DOI
-
- Mathuranath PS, George A, Ranjith N et al (2012) Incidence of Alzheimer’s disease in India: a 10 years follow-up study. Neurol India 60:625–630. https://doi.org/10.4103/0028-3886.105198 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous